Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study.

Nguyen, B O; Meems, L M G; van Faassen, M; Crijns, H J G M; van Gelder, I C; Kuipers, F; Rienstra, M

Nguyen, B O; Meems, L M G; van Faassen, M; Crijns, H J G M; van Gelder, I C; Kuipers, F; Rienstra, M.

Afiliação

Nguyen BO; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Meems LMG; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
van Faassen M; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Crijns HJGM; Maastricht University Medical Center+ and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
van Gelder IC; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Kuipers F; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Rienstra M; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Int J Cardiol Heart Vasc ; 34: 100798, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34095450

Palavras-chave

AF progression; Atrial fibrillation; Gut microbiome; TMAO

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google